Didier Saur

Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy ( <scp>VERTIS MET</scp> )

Julio Rosenstock, Juan P. Frías, Dénes Páll et al. · Diabetes Obesity and Metabolism · 2017 · 189 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone

Steven G. Terra, Kristen Focht, Melanie J. Davies et al. · Diabetes Obesity and Metabolism · 2017 · 145 citations

Medicine, Pharmacology, Pharmacotherapy +17

The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus

Vaishali Sahasrabudhe, Steven G. Terra, A. Hickman et al. · The Journal of Clinical Pharmacology · 2017 · 48 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Novel Application of the Two‐Period Microtracer Approach to Determine Absolute Oral Bioavailability and Fraction Absorbed of Ertugliflozin

Sangeeta Raje, Ernesto Callegari, Vaishali Sahasrabudhe et al. · Clinical and Translational Science · 2018 · 41 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Assessment of the Drug Interaction Potential of Ertugliflozin With Sitagliptin, Metformin, Glimepiride, or Simvastatin in Healthy Subjects

Vikas Kumar Dawra, David L. Cutler, Susan Zhou et al. · Clinical Pharmacology in Drug Development · 2018 · 29 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16